The Therapeutic Potential of Pyroptosis in Melanoma

Nadia Zaffaroni1, Giovanni L Beretta1

  • 1Molecular Pharmacology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.

Insights

Pyroptosis, a programmed cell death, involves membrane rupture and inflammation. This review explores its pathways and therapeutic potential in cancer, especially melanoma.

Area of Science:

  • Cell Biology
  • Immunology
  • Oncology

Background:

  • Pyroptosis is a programmed cell death mechanism causing membrane rupture and inflammation.
  • It involves four pathways: canonical, non-canonical, caspase-mediated, and caspase-independent.
  • Initially identified as an anti-pathogen defense, pyroptosis also influences tumor development and treatment response.

Purpose of the Study:

  • To review the cellular pathways of pyroptosis.
  • To discuss the therapeutic potential of inducing pyroptosis in cancer treatment.
  • To specifically examine pyroptosis in melanoma.

Main Methods:

  • Literature review of pyroptosis mechanisms.
  • Analysis of pyroptosis's role in tumor biology.
  • Exploration of pyroptosis induction as a cancer therapy strategy.

Main Results:

  • Pyroptosis has diverse cellular mechanisms and roles beyond infection defense.
  • It is implicated in tumor initiation, progression, metastasis, and drug response.
  • Pyroptosis induction is observed in various cancers like lung, colorectal, gastric, hepatocellular carcinoma, and melanoma.

Conclusions:

  • Pyroptosis is a multifaceted cell death pathway with significant implications in cancer.
  • Targeting pyroptosis offers a promising therapeutic avenue for various cancers.
  • Further research into pyroptosis induction, particularly in melanoma, is warranted for clinical application.